These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2289518)

  • 21. Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho P; Haapasalo H
    J Cancer Res Clin Oncol; 1992; 118(8):615-20. PubMed ID: 1517282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R
    Eur J Cancer; 1992; 29A(1):69-75. PubMed ID: 1445749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
    Lipponen P; Eskelinen M
    Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M; Nordling S
    Br J Urol; 1990 Jun; 65(6):589-97. PubMed ID: 2372672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
    Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E
    Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.
    Mangrud OM; Gudlaugsson E; Skaland I; Tasdemir I; Dalen I; van Diermen B; Baak JP; Janssen EA
    Hum Pathol; 2014 Jul; 45(7):1496-503. PubMed ID: 24796506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
    Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
    Lipponen PK; Eskelinen MJ
    Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.
    Bol MG; Baak JP; de Bruin PC; Rep S; Marx W; Bos S; Kisman O
    J Clin Pathol; 2001 Nov; 54(11):854-9. PubMed ID: 11684720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical prognostic factors in transitional cell cancer of the bladder.
    Lipponen PK; Eskelinen M; Jauhiainen K; Terho R; Harju E
    Urol Int; 1993; 50(4):192-7. PubMed ID: 8506588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder.
    Lipponen PK; Kosma VM; Collan Y; Kulju T; Kosunen O; Eskelinen M
    Eur Urol; 1990; 17(4):333-7. PubMed ID: 2364975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereologically measured nuclear volume in comparison to two-dimensional nuclear morphometry, mitotic index and flow cytometry in predicting disease outcome in bladder cancer.
    Lipponen PK
    Anticancer Res; 1993; 13(2):529-32. PubMed ID: 8517668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
    Bol MG; Baak JP; Rep S; Marx WL; Kruse AJ; Bos SD; Kisman O; Voorhorst FJ
    Urology; 2002 Dec; 60(6):1124-30. PubMed ID: 12475695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
    Lipponen PK; Aaltomaa S
    J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium.
    Jannink I; van Diest PJ; Baak JP
    Hum Pathol; 1995 Oct; 26(10):1086-92. PubMed ID: 7557941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.
    Liukkonen TJ; Lipponen PK; Helle M; Haapasalo HK; Nordling S; Rajala P
    Urol Res; 1996; 24(1):61-6. PubMed ID: 8966844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
    Zaleski M; Gogoj A; Walter V; Raman JD; Kaag M; Merrill SB; Drabick J; Joshi M; Holder S; DeGraff DJ; Warrick JI
    Hum Pathol; 2019 Feb; 84():275-282. PubMed ID: 30359638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volume-corrected mitotic index in human pancreatic cancer. Relation to histologic grade, clinical stage, and prognosis.
    Lipponen PK; Eskelinen MJ; Collan Y; Marin S; Alhava E
    Scand J Gastroenterol; 1990 Jun; 25(6):548-54. PubMed ID: 2359985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.